The London Market caters to all needs from a Directors’ & Officers’ (D&O) standpoint, from private and OTC traded companies to large publicly traded global companies.
Given the recent claims trends, Clients have been keen to purchase more capacity. Furthermore, with the hardening market, the current capacity and new capacity that has become available in the London market has certainly made it a key player in this space whether that be from a primary, excess or Side A DIC standpoint.
- Mid Cap Biotech/Tech
- Claims effected risks
- Distressed / bankruptcy exposed risks
- OTC Traded
- Reverse Mergers